Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The Journal of Experimental Medicine
|
July 1, 1995
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
A Porgador, E Gilboa
The International Journal of Biochemistry & Cell Biology
|
October 19, 2001
NKp46
O Mandelboim, A Porgador
Natural Immunity
|
March 1, 1994
Immunotherapy of tumor metastasis via gene therapy
A Porgador, M Feldman, L Eisenbach
Journal of Immunogenetics
|
August 1, 1989
H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence
A Porgador, M Feldman, L Eisenbach
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Induction of antitumor immunity using bone marrow-generated dendritic cells
A Porgador, D Snyder, E Gilboa
Immunology
|
August 14, 1999
Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens
R Song, A Porgador, C V Harding
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1991
Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor
A Porgador, B Brenner, E Vadai, et al.
Cancer Research
|
November 1, 1995
Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases
A Porgador, E Tzehoval, E Vadai, et al.
Infection and Immunity
|
November 24, 1998
Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue
A Porgador, H F Staats, Y Itoh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 16, 1997
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy
A Porgador, O Mandelboim, N P Restifo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The Journal of Experimental Medicine
|
July 1, 1995
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
A Porgador, E Gilboa
The International Journal of Biochemistry & Cell Biology
|
October 19, 2001
NKp46
O Mandelboim, A Porgador
Natural Immunity
|
March 1, 1994
Immunotherapy of tumor metastasis via gene therapy
A Porgador, M Feldman, L Eisenbach
Journal of Immunogenetics
|
August 1, 1989
H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence
A Porgador, M Feldman, L Eisenbach
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Induction of antitumor immunity using bone marrow-generated dendritic cells
A Porgador, D Snyder, E Gilboa
Immunology
|
August 14, 1999
Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens
R Song, A Porgador, C V Harding
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1991
Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor
A Porgador, B Brenner, E Vadai, et al.
Cancer Research
|
November 1, 1995
Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases
A Porgador, E Tzehoval, E Vadai, et al.
Infection and Immunity
|
November 24, 1998
Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue
A Porgador, H F Staats, Y Itoh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 16, 1997
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy
A Porgador, O Mandelboim, N P Restifo, et al.
Page
of 3